ArticleCancer medicine2018

MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.

Zhigang Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.